|Posted date||Jul 14, 2011|
|Date of filing||May 13, 2004|
|Gazette Date||Nov 25, 2004|
|Gazette Date||May 6, 2014|
|International application number||JP2004006793|
|International publication number||WO2004100965|
|Date of international filing||May 13, 2004|
|Date of international publication||Nov 25, 2004|
Disclosed is a new type of immunostimulating agent comprising an immunostimulating oligonucleotide complexed with a carrier which is safe and has a high transfection effect.
The carrier complexed with the immunostimulating oligonucleotide to form the immunostimulating agent is a polysaccharide having .beta.-1,3-bonds (preferably .beta.-1,3-glucan such as schizophyllan).
A preferred example of the immunostimulating oligonucleotide is one containing an unmethylated CpG motif.
The polysaccharide for use is preferably modified with nucleic acid-binding functional group and/or cell membrane-affinitive functional group.
|IPC(International Patent Classification)||
|Reference ( R and D project )||SORST Selected in Fiscal 2001|
※ Please contact us by E-mail or facsimile if you have any interests on this patent.
Contact Information for " Immunostimulating agents "
- Japan Science and Technology Agency Department of Intellectual Property Management
- URL: http://www.jst.go.jp/chizai/
- Address: 5-3, Yonbancho, Chiyoda-ku, Tokyo, Japan , 102-8666
- Fax: 81-3-5214-8476